We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Pregnant Women Can Now Test for Amniotic Fluid Leakage at Home

By LabMedica International staff writers
Posted on 29 Aug 2008
A new at-home screening for amniotic fluid leakage during pregnancy could help control a condition that may lead to serious complications such as infections and preterm labor.

The AmniScreen home detection kit is located in a panty liner, and is intended for pregnant women who experience unexplained vaginal wetness. More...
Other potential candidates include high-risk pregnant women, women who have undergone amniocentesis, women who have experienced prior amniotic fluid leakage, and those who are concerned about unexplained wetness. Each AmniScreen test kit contains three panty liners and three drying trays, offering screening in any location. The system works by detecting elevated pH levels, which may indicate amniotic fluid leakage; a pH level greater than or equal to 5.2 produces a blue-green color. Patients are then instructed to report the test results to their healthcare provider for interpretation and medical care. The test should not be used if less than 12 hours have passed since sexual intercourse or vaginal douching, and if there is vaginal bleeding or spotting. The AmniScreen home detection kit is a product of Barr Pharmaceuticals (Montvale, NJ, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"It's important to know when wetness may be caused by amniotic fluid leakage,” said Nancy Jasper, M.D., an assistant clinical professor of obstetrics and gynecology at Columbia University (New York, NY, USA). "This new tool provides pregnant women with an effective way to identify unexplained wetness, with easy-to-read results that should be discussed with their healthcare provider. This important new test is an additional resource which may provide healthcare providers with information to help determine the necessity of a patient hospital or office visit.”

Over 20% of women arriving at the hospital due to wetness they suspect to be caused by amniotic fluid leakage are sent back home after verifying the cause of the wetness is urine (many third trimester pregnancies are accompanied with urine incontinence, specifically when coughing or laughing). On the other hand, many pregnant women do not react to initial amniotic fluid leakage, as they are sure the wetness they sense is from urine incontinence or vaginal discharge, endangering both themselves and the fetus.

Related Links:
Barr Pharmaceuticals


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.